Hormone Therapy for Postmenopausal Women

被引：127

作者：

Pinkerton, JoAnn, V ^{[1
]}

机构：

[1] Univ Virginia Hlth Syst, Box 8041014, Charlottesville, VA 22908 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 382卷 / 05期

关键词：

BREAST-CANCER RISK; VASOMOTOR SYMPTOMS; MENOPAUSAL SYMPTOMS; REPLACEMENT THERAPY; HEALTH; ESTROGEN; MANAGEMENT; SOCIETY; ENDOCRINOLOGY; ASSOCIATION;

D O I：

10.1056/NEJMcp1714787

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hormone therapy is highly effective for the management of vasomotor symptoms in postmenopausal women; vaginal estrogen is used for genitourinary symptoms only. Hormone therapy is not recommended for primary or secondary prevention of coronary heart disease or dementia. Several nonhormonal therapies are also effective for vasomotor symptoms.

引用

页码：446 / 455

页数：10

共 53 条

[1] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].

Anderson, GL ;

Limacher, M ;

Assaf, AR ;

Bassford, T ;

Beresford, SAA ;

Black, H ;

Bonds, D ;

Brunner, R ;

Brzyski, R ;

Caan, B ;

Chlebowski, R ;

Curb, D ;

Gass, M ;

Hays, J ;

Heiss, G ;

Hendrix, S ;

Howard, BV ;

Hsia, J ;

Hubbell, A ;

Jackson, R ;

Johnson, KC ;

Judd, H ;

Kotchen, JM ;

Kuller, L ;

LaCroix, AZ ;

Lane, D ;

Langer, RD ;

Lasser, N ;

Lewis, CE ;

Manson, J ;

Margolis, K ;

Ockene, J ;

O'Sullivan, MJ ;

Phillips, L ;

Prentice, RL ;

Ritenbaugh, C ;

Robbins, J ;

Rossouw, JE ;

Sarto, G ;

Stefanick, ML ;

Van Horn, L ;

Wactawski-Wende, J ;

Wallace, R ;

Wassertheil-Smoller, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712

[2]

[Anonymous], 2016, OBSTET GYNECOL, V127, pE93

[3]

[Anonymous], 2014, Obstet Gynecol, V123, P202, DOI 10.1097/01.AOG.0000441353.20693.78

[4] Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition [J].

Avis, Nancy E. ;

Crawford, Sybil L. ;

Greendale, Gail ;

Bromberger, Joyce T. ;

Everson-Rose, Susan A. ;

Gold, Ellen B. ;

Hess, Rachel ;

Joffe, Hadine ;

Kravitz, Howard M. ;

Tepper, Ping G. ;

Thurston, Rebecca C. .

JAMA INTERNAL MEDICINE, 2015, 175 (04) :531-539

[5] 2016 IMS Recommendations on women's midlife health and menopause hormone therapy [J].

Baber, R. J. ;

Panay, N. ;

Fenton, A. .

CLIMACTERIC, 2016, 19 (02) :109-150

[6] Vaginal estrogen use and chronic disease risk in the Nurses' Health Study [J].

Bhupathiraju, Shilpa N. ;

Grodstein, Francine ;

Stampfer, Meir J. ;

Willett, Walter C. ;

Crandall, Carolyn J. ;

Shifren, Jan L. ;

Manson, JoAnn E. .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (06) :603-610

[7] Menopausal hormone therapy and risk of endometrial cancer [J].

Brinton, Louise A. ;

Felix, Ashley S. .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2014, 142 :83-89

[8] Oral versus transdermal estrogens and venous thromboembolism in postmenopausal women: what is new since 2003? [J].

Canonico, Marianne ;

Scarabin, Pierre-Yves .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (06) :587-588

[9] AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE [J].

Cobin, Rhoda H. ;

Goodman, Neil F. .

ENDOCRINE PRACTICE, 2017, 23 (07) :869-880

[10] Oestrogen therapy for urinary incontinence in postmenopausal women [J].

Cody, June D. ;

Richardson, Karen ;

Moehrer, Birgit ;

Hextall, Andrew ;

Glazener, Cathryn M. A. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04)

← 1 2 3 4 5 6 →